The Four Pillars of the American College of Cardiology
EDUCATION, ADVOCACY, SCIENCE & QUALITY
2012: The Year Focusing On Patient-centered Care & Education
|
Campaign for Patient Access
Click here to see what you can do!
|
The purpose of the Chapter is to contribute to the prevention of cardiovascular diseases and to ensure optimal quality of care for individuals with such diseases. In carrying out these purposes, the Chapter functions, in consultation with the leadership of the College,
as a source of advice to local and state governmental and professional organizations concerning issues related to cardiovascular disease. The Chapter, in the interest of patients, physicians, and the public in general, maintains a high level of social consciousness and involvement with socioeconomic factors and access to the highest possible quality of cardiovascular health care.
_________________________________________________________________________________________________
National Coverage Determination (NCD) for Percutaneous Transluminal Angioplasty (20.7) Concurrent with Carotid Artery Stenting in Patients at High Risk for Carotid Endarterectomy
This special edition MLN Matters article (SE 1119) contains no changes to current policy. This article clarifies current policies regarding Percutaneous Transluminal Angioplasty (PTA) and Carotid Artery Stenting (CAS). The National Coverage Determination (NCD 20.7 for PTA of the carotid artery concurrent with stenting is not changed by the new FDA-approved indications for the RX Acculink carotid stent in patients who are not at high risk for Carotid Endarterectomy (CEA). Providers are encouraged to review the information and to share with their staff.
http://www.palmettogba.com/palmetto/providers.nsf/ls/J1B~8HKLML2250?opendocument&utm_source=J1BL&utm_campaign=J1BLs&utm_medium=email
Important:! Cuts for not e-prescribing coming soon to your membership!
For questions regarding selecting and purchasing an e-prescribing system, please contact ACC’s Health Information Technology Department at jkreuter@acc.org. For more information regarding Medicare’s e-prescribing program and requirements, please contact ACC’s Advocacy Division at (800) 435-9203 or via e-mail at advodiv@acc.org.
|
